Z-Endoxifen manufactured for the National Cancer Institute

IriSys is privileged to have manufactured capsules of Z-Endoxifen for the National Cancer Institute that made a major difference in the life of a cancer patient in a Mayo Clinic trial.  We invite you to watch the following brief video, which shows why researchers are encouraged by the early results for patients using Z-Endoxifen:

Further reading: https://newsnetwork.mayoclinic.org/discussion/new-breast-cancer-drug-is-very-exciting/.

IriSys offers cGMP manufacturing services for clinical trial materials and commercial pharmaceutical products. Please contact us for further information.
Please follow and like us:

Welcome to Societal™
Recro has a new name. And, with it, a renewed sense of what we can accomplish with our partners to expedite the delivery of life-changing pharmaceuticals to patients. Together, we are truly Bringing Science To Society. You will soon be able to explore our vision with the upcoming launch of our new website.